- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01443793
Longitudinal Pattern of Streptococcus Pneumoniae Nasopharyngeal Carriage and Antimicrobial Susceptibility in Healthy Children Aged Less Then 5 Years, in the Area of Milan and Surroundings, Lombardy, Italy.
The objective of this active surveillance study is to make available crucial data about epidemiology, serotype distribution, and longitudinal pattern of antibiotic susceptibility of nasopharyngeal strains of Streptococcus pneumoniae carried in the population of healthy children aged less than years and living in the area of Milan and surroundings, Lombardy, Italy.
- To estimate the nasopharyngeal carriage rate and longitudinal pattern of Streptococcus pneumoniae in healthy children aged less than 5 years living in the area of Milan, Italy;
- To describe the circulation of antimicrobial non-susceptible Streptococcus pneumoniae strains in healthy children aged less than 5 years
Secondary objectives:
- To describe the nasopharyngeal carriage distribution of Streptococcus pneumoniae strains in healthy subjects less than 5 years old;
- To examine the role of risk factors in the Streptococcus pneumoniae carriage rate in healthy children;
- • To evaluate the possible impact of vaccination policy in the referenced population.
Study Overview
Status
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Milano, Italy, 20157
- Recruiting
- AO L.Sacco
-
Contact:
- Phone Number: 00390239042253
-
Principal Investigator:
- Gian Vincenzo Zuccotti, Professor
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- To estimate the nasopharyngeal carriage rate and longitudinal pattern of Streptococcus pneumoniae in healthy children aged less than 5 years living in the area of Milan, Italy;
- To describe the circulation of antimicrobial non-susceptible Streptococcus pneumoniae strains in healthy children aged less than5 years
Exclusion Criteria:
- To describe the nasopharyngeal carriage distribution of Streptococcus pneumoniae strains in healthy subjects less than 5 years old;
- To examine the role of risk factors in the Streptococcus pneumoniae carriage rate in healthy children;
- To evaluate the possible impact of vaccination policy in the referenced population..
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
• circulation of antimicrobial non-susceptible Streptococcus pneumoniae strains in healthy children aged less than 5 years
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
• the nasopharyngeal carriage distribution of Streptococcus pneumoniae strains in healthy subjects less than 5 years old;
Time Frame: 1 year
|
1 year
|
• the role of risk factors in the Streptococcus pneumoniae carriage rate in healthy children;
Time Frame: 1 year
|
1 year
|
• the possible impact of vaccination policy in the referenced population
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pneumo01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Streptococcus Pneumoniae Nasopharyngeal Carriage
-
Arto PalmuGlaxoSmithKlineCompletedNasopharyngeal Carriage of Streptococcus PneumoniaeFinland
-
Boston Medical CenterMerck Sharp & Dohme LLCCompletedNasopharyngeal Carriage of S. PneumoniaeUnited States
-
Medical Corps, Israel Defense ForceCompletedGroup A Streptococcus | Streptococcus Pneumonia | Carriage
-
Pierre Van DammeCentre Hospitalier Intercommunal Creteil; University of Bristol; University Ghent and other collaboratorsCompletedStreptococcus Pneumoniae | Nasopharyngeal CarriageBelgium
-
Universidad de la SabanaRecruitingCommunity-acquired Pneumonia | Streptococcus Pneumoniae Infection | Streptococcus Pneumoniae Pneumonia | Streptococcus Pneumoniae Infection InvasiveColombia
-
PfizerCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedStreptococcus Pneumoniae InfectionsChina
-
University of OxfordPfizerUnknownStreptococcal Pneumonia | Streptococcus Pneumoniae Infection | Streptococcus Pneumoniae, Invasive DiseaseUnited Kingdom
-
UMC UtrechtNetherlands: Ministry of Health, Welfare and Sports; Netherlands Vaccine InstituteCompletedStreptococcus Pneumoniae Infection
-
GlaxoSmithKlineCompletedStreptococcus Pneumoniae VaccinesSweden